{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T10:22:55Z","timestamp":1793528575344,"version":"4.5.0"},"reference-count":350,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":837,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jhep.2010.11.006","type":"journal-article","created":{"date-parts":[[2010,11,18]],"date-time":"2010-11-18T04:29:57Z","timestamp":1290054597000},"page":"773-794","source":"Crossref","is-referenced-by-count":517,"title":["Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver"],"prefix":"10.1016","volume":"54","author":[{"given":"Karima","family":"Begriche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Massart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Borgne-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Fromenty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2010.11.006_b0005","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0399-8320(04)95062-2","article-title":"Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs","volume":"28","author":"Biour","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jhep.2010.11.006_b0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(00)80417-1","article-title":"Drug-induced liver diseases","volume":"32","author":"Larrey","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0029-1240004","article-title":"The natural history of drug-induced liver injury","volume":"29","author":"Bj\u00f6rnsson","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2010.11.006_b0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/hep.23317","article-title":"Oral medications with significant hepatic metabolism at higher for hepatic adverse events","volume":"51","author":"Lammert","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0163-7258(95)00012-6","article-title":"Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity","volume":"67","author":"Fromenty","year":"1995","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1472-8206.2008.00608.x","article-title":"Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies","volume":"22","author":"Labbe","year":"2008","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-642-00663-0_11","article-title":"Mitochondrial involvement in drug-induced liver injury","volume":"196","author":"Pessayre","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2004.09.015","article-title":"Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice","volume":"42","author":"Masubuchi","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1979.tb12934.x","article-title":"The ninth sir hans Krebs lecture. Compartmentation and communication in living systems. Ligand conduction: a general catalytic principle in chemical, osmotic and chemiosmotic reaction systems","volume":"95","author":"Mitchell","year":"1979","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jhep.2010.11.006_b0050","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1742-4658.2006.05213.x","article-title":"The mitochondrial permeability transition from in vitro artifact to disease target","volume":"27","author":"Bernardi","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.jhep.2010.11.006_b0055","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.yjmcc.2009.03.006","article-title":"A CaPful of mechanisms regulating the mitochondrial permeability transition","volume":"46","author":"Di Lisa","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jhep.2010.11.006_b0060","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1002\/hep.21062","article-title":"Apoptosis and necrosis in the liver: a tale of two deaths?","volume":"43","author":"Malhi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd3137","article-title":"Targeting mitochondria for cancer therapy","volume":"9","author":"Fulda","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2010.11.006_b0070","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0168-8278(99)80360-2","article-title":"Withdrawal of life support, altruistic suicide, fratricidal killing and euthanasia by lymphocytes: different forms of drug-induced hepatic apoptosis","volume":"31","author":"Pessayre","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0075","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/74994","article-title":"Mitochondrial control of cell death","volume":"6","author":"Kroemer","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2010.11.006_b0080","doi-asserted-by":"crossref","first-page":"e9924","DOI":"10.1371\/journal.pone.0009924","volume":"5","author":"Buron","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2010.11.006_b0085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0009-2797(01)00283-6","article-title":"Mitochondrial injury by disulfiram: two different mechanisms of the mitochondrial permeability transition","volume":"138","author":"Balakirev","year":"2001","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jhep.2010.11.006_b0090","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10863-009-9230-x","article-title":"Physiological aspects of the mitochondrial cyclosporin A-insensitive palmitate\/Ca2+-induced pore: tissue specificity, age profile and dependence on the animal\u2019s adaptation to hypoxia","volume":"41","author":"Belosludtsev","year":"2009","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.jhep.2010.11.006_b0095","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.neurobiolaging.2006.06.022","article-title":"Role of cyclophilin D in the resistance of brain mitochondria to the permeability transition","volume":"28","author":"Eliseev","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jhep.2010.11.006_b0100","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/jnr.22239","article-title":"3-Nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions","volume":"88","author":"Mirandola","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jhep.2010.11.006_b0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.cdd.4401320","article-title":"Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis","volume":"11","author":"Maianski","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jhep.2010.11.006_b0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.4.110807.092314","article-title":"Mitochondrial energetics and therapeutics","volume":"5","author":"Wallace","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jhep.2010.11.006_b0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/BJ20041533","article-title":"Demonstration of N- and C-terminal domain intramolecular interactions in rat liver carnitine palmitoyltransferase 1 that determine its degree of malonyl-CoA sensitivity","volume":"387","author":"Faye","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2010.11.006_b0120","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1016\/S0021-9258(17)34693-8","article-title":"Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA","volume":"253","author":"McGarry","year":"1978","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b0125","doi-asserted-by":"crossref","first-page":"28918","DOI":"10.1074\/jbc.M910350199","article-title":"Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting","volume":"275","author":"Hashimoto","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b0130","doi-asserted-by":"crossref","first-page":"78R","DOI":"10.1203\/01.PDR.0000159631.63843.3E","article-title":"Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management","volume":"57","author":"Shekhawat","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jhep.2010.11.006_b0135","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/hep.22101","article-title":"Inhibition of mitochondrial fatty acid oxidation in vivo only slightly suppresses gluconeogenesis but enhances clearance of glucose in mice","volume":"47","author":"Derks","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.2042-7158.1969.tb08202.x","article-title":"A comparison of the effects on blood glucose and ketone-body levels, and of the toxicities, of pent-4-enoic acid and four simple fatty acids","volume":"21","author":"Senior","year":"1969","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.genet.39.110304.095751","article-title":"A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine","volume":"39","author":"Wallace","year":"2005","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.jhep.2010.11.006_b0150","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0022-3565(25)22965-2","article-title":"Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and II","volume":"255","author":"Fromenty","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0155","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1074\/jbc.M109.026203","article-title":"Electron transport chain-dependent and -independent mechanisms of mitochondrial H2O2 emission during long-chain fatty acid oxidation","volume":"285","author":"Seifert","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b0160","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1089\/ars.2009.2695","article-title":"Mitochondrial glutathione, a key survival antioxidant","volume":"11","author":"Mari","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jhep.2010.11.006_b0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.taap.2004.10.001","article-title":"Hepatic mitochondrial glutathione: transport and role in disease and toxicity","volume":"204","author":"Fernandez-Checa","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1124\/mi.10.2.7","article-title":"Mechanisms of pathogenesis in drug hepatotoxicity","volume":"10","author":"Jones","year":"2010","journal-title":"Putting the stress on mitochondria. Mol Interv"},{"key":"10.1016\/j.jhep.2010.11.006_b0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2004.10.016","article-title":"Mitochondrial H(+) leak and ROS generation: an odd couple","volume":"38","author":"Brookes","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2010.11.006_b0180","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.freeradbiomed.2009.02.008","article-title":"Tissue-, substrate- and site-specific characteristics of mitochondrial reactive oxygen species generation","volume":"46","author":"Tahara","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2010.11.006_b0185","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1053\/gast.2002.35952","article-title":"Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice","volume":"123","author":"Demeilliers","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b0190","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1096\/fj.05-5568com","article-title":"Methionine restriction decreases mitochondrial oxygen radical generation and leak as well as oxidative damage to mitochondrial DNA and proteins","volume":"20","author":"Sanz","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2010.11.006_b0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2004.03.005","article-title":"Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine","volume":"199","author":"Velsor","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1262-3636(07)70098-8","article-title":"The ins and outs of mitochondrial dysfunction in NASH","volume":"30","author":"Fromenty","year":"2004","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jhep.2010.11.006_b0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/187152106777697871","article-title":"Mitochondrial, metabolic and genotoxic effects of antiretroviral nucleoside reverse-transcriptase inhibitors","volume":"5","author":"Igoudjil","year":"2006","journal-title":"Anti-Infective Agents in Medicinal Chemistry"},{"key":"10.1016\/j.jhep.2010.11.006_b0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mito.2009.09.006","article-title":"Energetics, epigenetics, mitochondrial genetics","volume":"10","author":"Wallace","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jhep.2010.11.006_b0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.abb.2007.03.034","article-title":"Selective degradation of mitochondria by autophagia","volume":"462","author":"Kim","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jhep.2010.11.006_b0220","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0168-8278(02)00021-1","article-title":"Progressive reversion of clinical and molecular phenotype in a child with liver mitochondrial DNA depletion","volume":"36","author":"Ducluzeau","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0225","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1042\/bj20021594","article-title":"Mitochondrial threshold effects","volume":"370","author":"Rossignol","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2010.11.006_b0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0921-8777(99)00025-7","article-title":"Mitochondrial DNA repair pathways","volume":"434","author":"Croteau","year":"1999","journal-title":"Mutat Res"},{"key":"10.1016\/j.jhep.2010.11.006_b0235","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0079-6603(01)68107-8","article-title":"Base excision repair in nuclear and mitochondrial DNA","volume":"68","author":"Dianov","year":"2001","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"10.1016\/j.jhep.2010.11.006_b0240","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.freeradbiomed.2009.05.006","article-title":"Acyl-CoA-induced generation of reactive oxygen species in mitochondrial preparations is due to the presence of peroxisomes","volume":"47","author":"Sch\u00f6nfeld","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2010.11.006_b0245","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1042\/bj2180697","article-title":"Peroxisomal \u03b2-oxidation from endogenous substrates. Demonstration through H2 O2 production in the unanaesthetized mouse","volume":"218","author":"Van den Branden","year":"1984","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2010.11.006_b0250","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0925-4439(95)00084-4","article-title":"Hydrogen peroxide metabolism during peroxisome proliferation by fenofibrate","volume":"1272","author":"Arnaiz","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2010.11.006_b0255","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.bcp.2008.03.004","article-title":"Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases","volume":"75","author":"Hardwick","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0260","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1016\/S0021-9258(18)31472-8","article-title":"Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1","volume":"268","author":"Laethem","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b0265","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0006-2952(84)90376-9","article-title":"Antimitochondrial effect of saturated medium chain length (C8\u2013C13) dicarboxylic acids","volume":"33","author":"Passi","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0270","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1074\/jbc.M510484200","article-title":"Overexpression of CYP2E1 in mitochondria sensitizes HepG2 cells to the toxicity caused by depletion of glutathione","volume":"281","author":"Bai","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b0275","doi-asserted-by":"crossref","first-page":"24609","DOI":"10.1074\/jbc.M110.121822","article-title":"Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress","volume":"285","author":"Bansal","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b0280","doi-asserted-by":"crossref","first-page":"40583","DOI":"10.1074\/jbc.M203292200","article-title":"Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation","volume":"277","author":"Robin","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b0285","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.mito.2008.02.001","article-title":"Nuclear receptors, mitochondria and lipid metabolism","volume":"8","author":"Alaynick","year":"2008","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jhep.2010.11.006_b0290","doi-asserted-by":"crossref","first-page":"27950","DOI":"10.1074\/jbc.M100258200","article-title":"Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells","volume":"276","author":"Hsu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b0295","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0005-2760(96)00066-5","article-title":"The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation","volume":"1302","author":"Schoonjans","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2010.11.006_b0300","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.ddmec.2009.02.002","article-title":"Mitochondrial dysfunction in nonalcoholic steatohepatitis (NASH): are there drugs able to improve it?","volume":"6","author":"Begriche","year":"2009","journal-title":"Drug Discov Today Dis Mech"},{"key":"10.1016\/j.jhep.2010.11.006_b0305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2009.02.017","article-title":"PPAR-mediated activity of phthalates: a link to the obesity epidemic?","volume":"304","author":"Desvergne","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jhep.2010.11.006_b0310","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/hep.22907","article-title":"A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocytes","volume":"49","author":"Moreau","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0315","first-page":"2347","article-title":"FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice","volume":"118","author":"Kamagate","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2010.11.006_b0320","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11695-009-9827-5","article-title":"Lipoprotein lipase expression in livers of morbidly obese patients could be responsible for liver steatosis","volume":"19","author":"Pardina","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/j.jhep.2010.11.006_b0325","doi-asserted-by":"crossref","first-page":"242S","DOI":"10.1038\/oby.2006.317","article-title":"Adipose tissue as an endocrine organ","volume":"14","author":"Ahima","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.jhep.2010.11.006_b0330","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1472-8206.2009.00765.x","article-title":"Effects of \u03b2-aminoisobutyric acid on leptin production and lipid homeostasis: mechanisms and possible relevance for the prevention of obesity","volume":"24","author":"Begriche","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0335","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2010.11.006_b0340","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.peptides.2009.07.021","article-title":"Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation","volume":"30","author":"Kalra","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.jhep.2010.11.006_b0345","doi-asserted-by":"crossref","first-page":"E939","DOI":"10.1152\/ajpendo.00379.2007","article-title":"Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice","volume":"294","author":"Begriche","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhep.2010.11.006_b0350","doi-asserted-by":"crossref","first-page":"980S","DOI":"10.3945\/ajcn.2008.26788C","article-title":"Leptin: a pivotal regulator of human energy homeostasis","volume":"89","author":"Farooqi","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jhep.2010.11.006_b0355","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.23046","article-title":"Adipokines in liver diseases","volume":"50","author":"Marra","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0360","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/hep.22444","article-title":"Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury","volume":"48","author":"Zhou","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0365","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-3476(79)80110-9","article-title":"Reye-like syndrome associated with valproic acid therapy","volume":"95","author":"Gerber","year":"1979","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2010.11.006_b0370","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","article-title":"Valproate-induced hepatic injury: analyses of 23 fatal cases","volume":"2","author":"Zimmerman","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0375","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0140-6736(91)91294-5","article-title":"Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy","volume":"337","author":"Arnaudo","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2010.11.006_b0380","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7326\/0003-4819-115-4-283","article-title":"Fulminant hepatic failure associated with 2\u2032,3\u2032-dideoxyinosine (ddI)","volume":"115","author":"Lai","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2010.11.006_b0385","first-page":"716","article-title":"Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease?","volume":"8","author":"Le Bras","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2010.11.006_b0390","first-page":"706","article-title":"The role of mitochondrial dysfunction and drug safety","volume":"12","author":"Nadanaciva","year":"2009","journal-title":"IDrugs"},{"key":"10.1016\/j.jhep.2010.11.006_b0395","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","article-title":"Mechanisms of hepatotoxicity","volume":"65","author":"Jaeschke","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhep.2010.11.006_b0400","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/01926230701584163","article-title":"Role of neutrophils in the pathogenesis of acute inflammatory liver injury","volume":"35","author":"Ramaiah","year":"2007","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jhep.2010.11.006_b0405","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/taap.1999.8635","article-title":"Inhibition of Fas receptor (CD95)-induced hepatic caspase activation and apoptosis by acetaminophen in mice","volume":"156","author":"Lawson","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0410","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/152308602760598873","article-title":"Reactive oxygen as modulator of TNF and fas receptor-mediated apoptosis in vivo: studies with glutathione peroxidase-deficient mice","volume":"4","author":"Bajt","year":"2002","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jhep.2010.11.006_b0415","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1124\/jpet.106.104125","article-title":"The anti-inflammatory drug, nimesulide (4-nitro-2-phenoxymethane-sulfoanilide), uncouples mitochondria and induces mitochondrial permeability transition in human hepatoma cells: protection by albumin","volume":"318","author":"Berson","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0420","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.20634","article-title":"Mechanisms of benzarone and benzbromarone-induced hepatic toxicity","volume":"41","author":"Kaufmann","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0425","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0022-3565(25)20745-5","article-title":"The mitochondrial permeability transition: a new pathophysiological mechanism for Reye\u2019s syndrome and toxic liver injury","volume":"278","author":"Trost","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0430","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0022-3565(24)29292-2","article-title":"Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem, in rat hepatocytes: role of mitochondrial permeability transition and metabolic activation","volume":"299","author":"Berson","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0435","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tox.2006.02.017","article-title":"Mitochondrial permeability transition as a potential determinant of hepatotoxicity of antidiabetic thiazolidinediones","volume":"222","author":"Masubuchi","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.jhep.2010.11.006_b0440","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0014-5793(01)02316-X","article-title":"Mitochondrial permeability transition and oxidative stress","volume":"495","author":"Kowaltowski","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhep.2010.11.006_b0445","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-642-00663-0_12","article-title":"Mechanisms of acetaminophen-induced liver necrosis","volume":"196","author":"Hinson","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0450","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1016\/S0021-9258(19)67754-9","article-title":"Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes","volume":"266","author":"Burcham","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b0455","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/tx800464q","article-title":"Serum metabolomics reveals irreversible inhibition of fatty acid \u03b2-oxidation through the suppression of PPAR\u03b1 activation as a contributing mechanism of acetaminophen-induced hepatotoxicity","volume":"22","author":"Chen","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jhep.2010.11.006_b0460","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/toxsci\/65.1.135","article-title":"Genomics and proteomics analysis of acetaminophen toxicity in mouse liver","volume":"65","author":"Ruepp","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhep.2010.11.006_b0465","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1053\/j.gastro.2008.08.031","article-title":"How to protect against acetaminophen: don\u2019t ask for JUNK","volume":"135","author":"Kaplowitz","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b0470","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1248\/bpb.31.273","article-title":"Protective effects of macelignan on cisplatin-induced hepatotoxicity is associated with JNK activation","volume":"31","author":"Sohn","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jhep.2010.11.006_b0475","first-page":"1205","article-title":"Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases","volume":"151","author":"Dong","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2010.11.006_b0480","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1053\/gast.1996.v110.pm8964414","article-title":"Uncoupling of rat and human mitochondria: a possible explanation for tacrine-induced liver dysfunction","volume":"110","author":"Berson","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b0485","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/0006-2952(77)90258-1","article-title":"In vitro effects of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation in rats liver mitochondria","volume":"26","author":"Tokumitsu","year":"1977","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0490","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.taap.2006.09.012","article-title":"Critical role of free cytosolic calcium, but not uncoupling, in mitochondrial permeability transition and cell death induced by diclofenac oxidative metabolites in immortalized human hepatocytes","volume":"217","author":"Lim","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0495","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-8278(00)00050-7","article-title":"Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation","volume":"34","author":"Berson","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0500","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-4274(98)00097-6","article-title":"Amiodarone-induced disruption of hamster lung and liver mitochondrial function: lack of association with thiobarbituric acid-reactive substance production","volume":"98","author":"Card","year":"1998","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jhep.2010.11.006_b0505","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/hep.1840190422","article-title":"Inhibition by perhexiline of oxidative phosphorylation and the \u03b2-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions","volume":"19","author":"Deschamps","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0510","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/jpet.106.114546","article-title":"Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver","volume":"321","author":"Larosche","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0515","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1124\/jpet.106.108993","article-title":"Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives","volume":"319","author":"Waldhauser","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0520","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0022-3565(25)20562-6","article-title":"Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye\u2019s syndrome","volume":"259","author":"Deschamps","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0525","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cbi.2009.11.024","article-title":"Salicylic acid-induced hepatotoxicity triggered by oxidative stress","volume":"183","author":"Doi","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jhep.2010.11.006_b0530","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0022-3565(25)22984-6","article-title":"Amiodarone inhibits the mitochondrial \u03b2-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice","volume":"255","author":"Fromenty","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0535","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-2952(96)00204-3","article-title":"Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone","volume":"52","author":"Kennedy","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0540","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-3565(25)22351-5","article-title":"Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen","volume":"270","author":"Berson","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0545","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/17843286.1990.11718105","article-title":"Microvesicular steatosis of the liver","volume":"45","author":"Hautekeete","year":"1990","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.jhep.2010.11.006_b0550","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1086\/323783","article-title":"Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases","volume":"33","author":"Coghlan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2010.11.006_b0555","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0016-5085(85)90765-6","article-title":"Pirprofen-induced fulminant hepatitis","volume":"89","author":"Danan","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b0560","first-page":"192","article-title":"Histopathologic changes associated with fialuridine hepatotoxicity","volume":"10","author":"Kleiner","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jhep.2010.11.006_b0565","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0168-8278(94)80237-8","article-title":"Tianeptine: an instance of drug-induced hepatotoxicity predicted by prospective experimental studies","volume":"21","author":"Le Bricquir","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0570","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0022-3565(25)39166-4","article-title":"Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug","volume":"242","author":"Gen\u00e8ve","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0575","first-page":"967","article-title":"Reye\u2019s syndrome-like illness in a patient receiving amiodarone","volume":"83","author":"Jones","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.11.006_b0580","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0046-8177(90)90076-H","article-title":"Histopathologic analysis of suspected amiodarone hepatotoxicity","volume":"21","author":"Lewis","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jhep.2010.11.006_b0585","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1023\/A:1005505827545","article-title":"Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin","volume":"46","author":"Caldwell","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2010.11.006_b0590","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0046-8177(00)80229-4","article-title":"Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: a case report with autopsy examination","volume":"31","author":"Fukano","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jhep.2010.11.006_b0595","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1572-0241.2000.01707.x","article-title":"Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration","volume":"95","author":"Kohlroser","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.11.006_b0600","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(95)90024-1","article-title":"Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis","volume":"108","author":"Fromenty","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b0605","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0146-0005(99)80052-4","article-title":"Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders","volume":"23","author":"Rinaldo","year":"1999","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0610","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.1840080513","article-title":"Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic","volume":"8","author":"Fr\u00e9neaux","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0615","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1023\/A:1022039206660","article-title":"Glucose-free medium exacerbates microvesicular steatosis in cultured skin fibroblasts of genetic defects of fatty acid oxidation. A novel screening test","volume":"25","author":"Renaud","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jhep.2010.11.006_b0620","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/jhep.2003.50309","article-title":"Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice","volume":"38","author":"Lett\u00e9ron","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0625","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/hep.22239","article-title":"Prevention of free fatty acid-induced hepatic lipotoxicity by 18-\u03b2-glycyrrhetinic acid through lysosomal and mitochondrial pathways","volume":"47","author":"Wu","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0630","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1528-1157.1997.tb01263.x","article-title":"Successful treatment by direct hemoperfusion of coma possibly resulting from mitochondrial dysfunction in acute valproate intoxication","volume":"38","author":"Matsumoto","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.jhep.2010.11.006_b0635","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0022-3565(24)37694-3","article-title":"Binding of nonsteroidal antiinflammatory drugs to the \u03b1-subunit of the trifunctional protein of long chain fatty acid oxidation","volume":"286","author":"Baldwin","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0640","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/0006-2952(89)90580-7","article-title":"Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice","volume":"38","author":"Fromenty","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0645","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0090-9556(25)07823-7","article-title":"Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates","volume":"13","author":"Rettenmeier","year":"1985","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2010.11.006_b0650","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0009-2797(01)00234-4","article-title":"Differential effect of valproate and its Delta2- and Delta4-unsaturated metabolites, on the beta-oxidation rate of long-chain and medium-chain fatty acids","volume":"137","author":"Silva","year":"2001","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jhep.2010.11.006_b0655","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.2008.058248","article-title":"Histological patterns in drug-induced liver disease","volume":"62","author":"Ramachandran","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jhep.2010.11.006_b0660","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.bcp.2009.10.011","article-title":"Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis","volume":"79","author":"Aires","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0665","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2337\/diab.45.11.1556","article-title":"Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats","volume":"45","author":"Fulgencio","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2010.11.006_b0670","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3565(25)22933-0","article-title":"Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids","volume":"255","author":"Fr\u00e9neaux","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0675","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/abio.2000.4947","article-title":"Synthesis and intramitochondrial levels of valproyl-coenzyme A metabolites","volume":"290","author":"Silva","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jhep.2010.11.006_b0680","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tox.2009.04.058","article-title":"Protective effect of bicyclol on tetracycline-induced fatty liver in mice","volume":"261","author":"Yu","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.jhep.2010.11.006_b0685","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1073\/pnas.93.8.3592","article-title":"Fialuridine and its metabolites inhibit DNA polymerase \u03b3 at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts","volume":"93","author":"Lewis","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2010.11.006_b0690","doi-asserted-by":"crossref","first-page":"M117","DOI":"10.1177\/135965350501002S13","article-title":"Uridine in the prevention and treatment of NRTI-related mitochondrial toxicity","volume":"10","author":"Walker","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0695","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0188-4409(02)00454-X","article-title":"Metabolic acidosis and hepatic steatosis in two HIV-infected patients on stavudine (d4T) treatment","volume":"34","author":"Cornejo-Juarez","year":"2003","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jhep.2010.11.006_b0700","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.20074","article-title":"Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine","volume":"39","author":"Walker","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0705","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1124\/jpet.105.088898","article-title":"Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity","volume":"315","author":"Cover","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b0710","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.taap.2009.07.021","article-title":"Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes","volume":"240","author":"Rachek","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0715","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/bbrc.1997.6786","article-title":"Action of mitochondrial endonuclease G on DNA damaged by l-ascorbic acid, peplomycin, and cis-diamminedichloroplatinum (II)","volume":"235","author":"Ikeda","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2010.11.006_b0720","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0016-5085(99)70566-4","article-title":"An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice","volume":"117","author":"Mansouri","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b0725","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1093\/nar\/gkp1082","article-title":"Analysis of differential DNA damage in the mitochondrial genome employing a semi-long run real-time PCR approach","volume":"38","author":"Rothfuss","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2010.11.006_b0730","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hep.510290353","article-title":"Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver","volume":"29","author":"de la Asuncion","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0735","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mrfmmm.2009.02.006","article-title":"Base excision repair and mitochondrial DNA mutation in human hepatic HuH-7 cells exposed to stavudine","volume":"664","author":"Wu","year":"2009","journal-title":"Mutat Res"},{"key":"10.1016\/j.jhep.2010.11.006_b0740","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1478-3231.1999.tb00044.x","article-title":"Macrovesicular steatosis induced by interferon alfa therapy for chronic myelogenous leukaemia","volume":"19","author":"Cast\u00e9ra","year":"1999","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2010.11.006_b0745","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-2002-30106","article-title":"Drugs and steatohepatitis","volume":"22","author":"Farrell","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2010.11.006_b0750","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00124743-200108000-00007","article-title":"Liver biopsy in psoriatic arthritis to detect methotrexate hepatotoxicity","volume":"7","author":"Grismer","year":"2001","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0755","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.5719","article-title":"Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases","volume":"94","author":"Zorzi","year":"2007","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2010.11.006_b0760","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0168-8278(97)80256-5","article-title":"A new model of acute liver steatosis induced in rats by fasting followed by refeeding a high carbohydrate-fat free diet. Biochemical and morphological analysis","volume":"26","author":"Delzenne","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0765","first-page":"419","article-title":"PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores","volume":"1791","author":"Bickel","year":"2009","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.jhep.2010.11.006_b0770","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","article-title":"Pathology of nonalcoholic fatty liver disease","volume":"7","author":"Brunt","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jhep.2010.11.006_b0780","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0785","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1530-0277.2009.01015.x","article-title":"Current experimental perspectives on the clinical progression of alcoholic liver disease","volume":"33","author":"Breitkopf","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2010.11.006_b0790","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.alcohol.2004.07.005","article-title":"Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha","volume":"34","author":"Crabb","year":"2004","journal-title":"Alcohol"},{"key":"10.1016\/j.jhep.2010.11.006_b0795","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0005-2760(94)90089-2","article-title":"The biochemistry of alcohol-induced fatty liver","volume":"1215","author":"Day","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2010.11.006_b0800","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.3748\/wjg.v13.i37.4974","article-title":"Alcohol-induced steatosis in liver cells","volume":"13","author":"Donohue","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.11.006_b0805","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2006.05.009","article-title":"Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model","volume":"45","author":"Ji","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0810","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/hep.22811","article-title":"Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats","volume":"49","author":"Chen","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0815","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/hep.22074","article-title":"Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease","volume":"47","author":"Song","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0820","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00204-009-0457-4","article-title":"Ethanol and liver: recent advances in the mechanisms of ethanol-induced hepatosteatosis","volume":"83","author":"Zeng","year":"2009","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jhep.2010.11.006_b0825","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3727\/105221609788681213","article-title":"Conditional ablation of mediator subunit MED1 (MED1\/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis","volume":"14","author":"Jia","year":"2009","journal-title":"Gene Expr"},{"key":"10.1016\/j.jhep.2010.11.006_b0830","first-page":"G1141","article-title":"Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid beta-oxidation","volume":"272","author":"Lett\u00e9ron","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2010.11.006_b0835","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.tiv.2008.01.011","article-title":"High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes","volume":"22","author":"Igoudjil","year":"2008","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.jhep.2010.11.006_b0840","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1194\/jlr.M300094-JLR200","article-title":"CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans","volume":"44","author":"Chandler","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2010.11.006_b0845","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/157016109788340703","article-title":"Future challenges for microsomal transport protein inhibitors","volume":"7","author":"Wierzbicki","year":"2009","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0850","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hep.23647","article-title":"Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells","volume":"52","author":"Blas-Garc\u00eda","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0855","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1748-1716.2009.01973.x","article-title":"AMP-activated protein kinase control of fat metabolism in skeletal muscle","volume":"196","author":"Thomson","year":"2009","journal-title":"Acta Physiol"},{"key":"10.1016\/j.jhep.2010.11.006_b0860","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0026-0495(91)90062-2","article-title":"Tumor necrosis factor-\u03b1, interleukin-1, and interferon-\u03b1 stimulate triglyceride synthesis in HepG2 cells","volume":"40","author":"Grunfeld","year":"1991","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2010.11.006_b0865","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1194\/jlr.M600148-JLR200","article-title":"Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver","volume":"47","author":"Gudbrandsen","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2010.11.006_b0870","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1677\/JOE-08-0054","article-title":"Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome","volume":"197","author":"Macfarlane","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jhep.2010.11.006_b0875","doi-asserted-by":"crossref","first-page":"E1195","DOI":"10.1152\/ajpendo.00513.2004","article-title":"PPAR\u03b32 regulates lipogenesis and lipid accumulation in steatotic hepatocytes","volume":"288","author":"Schadinger","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhep.2010.11.006_b0880","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cbi.2010.01.008","article-title":"Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile","volume":"184","author":"Moya","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jhep.2010.11.006_b0885","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/dmd.30.1.96","article-title":"A pharmacophore for human pregnane X receptor ligands","volume":"30","author":"Ekins","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2010.11.006_b0890","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00280-008-0842-3","article-title":"Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for pregnane X receptor","volume":"64","author":"Harmsen","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b0895","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0168-8278(01)00066-6","article-title":"Diabetic KKAy mice exhibit increased hepatic PPAR\u03b31 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones","volume":"35","author":"Bedoucha","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0900","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hep.21687","article-title":"Effects of rosiglitazone on the liver histology and mitochondrial function in ob\/ob mice","volume":"46","author":"Garcia-Ruiz","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b0905","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cmet.2008.08.001","article-title":"The glucocorticoid receptor controls hepatic dyslipidemia through Hes1","volume":"8","author":"Lemke","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2010.11.006_b0910","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/toxsci\/kfm154","article-title":"Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor","volume":"99","author":"Peffer","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhep.2010.11.006_b0915","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.3748\/wjg.v13.i42.5635","article-title":"Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse","volume":"13","author":"Baskin-Bey","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.11.006_b0920","doi-asserted-by":"crossref","first-page":"18831","DOI":"10.1073\/pnas.0909731106","article-title":"Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease","volume":"106","author":"Dong","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2010.11.006_b0925","doi-asserted-by":"crossref","first-page":"25984","DOI":"10.1074\/jbc.M109.016808","article-title":"The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity","volume":"284","author":"Gao","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b0930","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ajcp\/108.3.280","article-title":"2\u2032,3\u2032-Dideoxyinosine-induced Mallory bodies in patients with HIV","volume":"108","author":"Hu","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jhep.2010.11.006_b0935","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1515\/JPEM.2007.20.2.219","article-title":"Inappropriate use of potent topical glucocorticoids in infants","volume":"20","author":"Ozon","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jhep.2010.11.006_b0940","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0168-8278(95)80316-5","article-title":"Tamoxifen-associated steatohepatitis \u2013 report of three cases","volume":"23","author":"Pinto","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b0945","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1056\/NEJM198407193110308","article-title":"Amiodarone hepatotoxicity simulating alcoholic liver disease","volume":"311","author":"Simon","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.11.006_b0950","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.qai.0000221683.44940.62","article-title":"Severe liver disease associated with prolonged exposure to antiretroviral drugs","volume":"42","author":"Maida","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jhep.2010.11.006_b0955","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0016-5085(79)80145-6","article-title":"Perhexiline maleate-induced cirrhosis","volume":"76","author":"Pessayre","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b0960","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00000441-200511000-00012","article-title":"Hepatic cirrhosis caused by low-dose oral amiodarone therapy","volume":"330","author":"Puli","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jhep.2010.11.006_b0965","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cbf.290060110","article-title":"Methotrexate: studies on the cellular metabolism. I. Effect on mitochondrial oxygen uptake and oxidative phosphorylation","volume":"6","author":"Yamamoto","year":"1988","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.jhep.2010.11.006_b0970","doi-asserted-by":"crossref","unstructured":"Hardwick JP, Osei-Hyiaman D, Wiland H, Abdelmegeed MA, Song BJ. PPAR\/RXR regulation of fatty acid metabolism and fatty acid \u03c9-hydroxylase (CYP4) isozymes: implications for prevention of lipotoxicity in fatty liver disease. PPAR Res 2009;2009:952734, doi:10.1155\/2009\/952734.","DOI":"10.1155\/2009\/952734"},{"key":"10.1016\/j.jhep.2010.11.006_b0975","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","author":"Leclercq","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2010.11.006_b0980","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0016-5085(98)70590-6","article-title":"Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes","volume":"114","author":"Berson","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b0985","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.alcohol.2006.12.006","article-title":"Combined effects of high-fat diet and ethanol induce oxidative stress in rat liver","volume":"40","author":"Demori","year":"2006","journal-title":"Alcohol"},{"key":"10.1016\/j.jhep.2010.11.006_b0990","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1096\/fasebj.11.11.9285483","article-title":"The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor \u03b21 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis","volume":"11","author":"Leonarduzzi","year":"1997","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2010.11.006_b0995","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2353\/ajpath.2009.090332","article-title":"Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice","volume":"175","author":"Mitchell","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2010.11.006_b1000","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/jhep.2002.30362","article-title":"Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species","volume":"35","author":"Nieto","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1005","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1006\/bbrc.1993.1927","article-title":"Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells","volume":"194","author":"Parola","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2010.11.006_b1010","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0304-4165(98)00002-6","article-title":"Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits","volume":"1380","author":"Chen","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2010.11.006_b1015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-2797(89)90016-1","article-title":"Three models of free radical-induced cell injury","volume":"72","author":"Comporti","year":"1989","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jhep.2010.11.006_b1020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2010.11.006_b1025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-291X(88)81207-5","article-title":"Evidence for mitochondrial DNA damage by lipid peroxidation","volume":"153","author":"Hruszkewycz","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2010.11.006_b1030","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1074\/jbc.M610602200","article-title":"Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1\/2 activity via 4-hydroxynonenal","volume":"282","author":"Sampey","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b1035","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.tiv.2008.05.009","article-title":"Steatohepatitis-inducing drugs trigger cytokeratin cross-links in hepatocytes. Possible contribution to Mallory\u2013Denk body formation","volume":"22","author":"Robin","year":"2008","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.jhep.2010.11.006_b1040","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.biochi.2007.09.001","article-title":"Transforming growth factor beta mediates hepatocyte apoptosis through Smad3 generation of reactive oxygen species","volume":"89","author":"Black","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.jhep.2010.11.006_b1045","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.38391.663287.E0","article-title":"Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial","volume":"330","author":"Bruno","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2010.11.006_b1050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jamcollsurg.2005.01.024","article-title":"Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases","volume":"200","author":"Fernandez","year":"2005","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhep.2010.11.006_b1055","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jhep.2007.01.024","article-title":"Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment","volume":"46","author":"Rosenberg","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b1060","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1002\/cncr.24374","article-title":"The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer","volume":"115","author":"Saphner","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2010.11.006_b1065","doi-asserted-by":"crossref","first-page":"34268","DOI":"10.1074\/jbc.M300043200","article-title":"Liver peroxisome proliferator-activated receptor \u03b3 contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass","volume":"278","author":"Gavrilova","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b1070","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/oby.2008.419","article-title":"Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients","volume":"16","author":"Takamura","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.jhep.2010.11.006_b1075","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects","volume":"56","author":"Westerbacka","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2010.11.006_b1080","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2005.03.004","article-title":"NASH: a mitochondrial disease","volume":"42","author":"Pessayre","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b1085","doi-asserted-by":"crossref","first-page":"10143","DOI":"10.1074\/jbc.M510249200","article-title":"Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure","volume":"281","author":"Moreira","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b1090","first-page":"373","article-title":"Epidemiology of fatty liver in an islander population of China: a population-based case-control study","volume":"7","author":"Dai","year":"2008","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jhep.2010.11.006_b1095","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jhep.2009.05.021","article-title":"Cigarette smoke exposure: a novel cofactor of NAFLD progression?","volume":"51","author":"Mallat","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b1100","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/hep.20949","article-title":"Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-\u03baB to activate hepatic apoptosis in genetically obese mice","volume":"42","author":"Robin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1105","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhep.2010.11.006_b1110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0031-6997(25)00049-3","article-title":"Cationic amphiphilic drugs and phospholipid storage disorder","volume":"42","author":"Kodavanti","year":"1990","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jhep.2010.11.006_b1115","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.1840080514","article-title":"Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease","volume":"8","author":"Guigui","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbrc.2008.09.121","article-title":"Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes","volume":"377","author":"Ikeda","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2010.11.006_b1125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/EJE-08-0597","article-title":"R-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans","volume":"160","author":"Brennan","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jhep.2010.11.006_b1130","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2008-1588","article-title":"The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia","volume":"94","author":"Mulligan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhep.2010.11.006_b1135","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/135965350701200314","article-title":"High doses of stavudine induce fat wasting and mild liver damage without impairing mitochondrial respiration in mice","volume":"12","author":"Igoudjil","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1140","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1096\/fj.02-0158rev","article-title":"Analysis of paradoxical observations on the association between leptin and insulin resistance","volume":"16","author":"Ceddia","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2010.11.006_b1145","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1073\/pnas.94.9.4637","article-title":"Direct antidiabetic effect of leptin through triglyceride depletion of tissues","volume":"94","author":"Shimabukuro","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2010.11.006_b1150","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1096\/fj.07-094144","article-title":"AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing\u2019s syndrome","volume":"22","author":"Christ-Crain","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2010.11.006_b1155","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2337\/diabetes.54.8.2269","article-title":"Prooiomelanocortin-deficient mice are hypersensitive to the adverse metabolic effects of glucocorticoids","volume":"54","author":"Coll","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2010.11.006_b1160","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mai.2000.109830","article-title":"Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma","volume":"106","author":"Covar","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jhep.2010.11.006_b1165","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.steroids.2010.05.001","article-title":"Glucocorticoids decrease serum adiponectin level and WAT adiponectin mRNA expression in rats","volume":"75","author":"Shi","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.jhep.2010.11.006_b1170","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ajg.2009.717","article-title":"Non-alcoholic fatty liver disease in liver transplant recipients: another story of \u201cseed and soil\u201d","volume":"105","author":"Dumortier","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.11.006_b1175","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1262-3636(06)72809-9","article-title":"Immunosuppressive drug-induced diabetes","volume":"32","author":"Penfornis","year":"2006","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jhep.2010.11.006_b1180","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1124\/jpet.108.137240","volume":"326","author":"Coccurello","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment \u2013 pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1190","doi-asserted-by":"crossref","unstructured":"Albaugh VL, Judson JG, She P, Lang CH, Maresca KP, Joyal JL, et al. Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis. Mol Psychiatry, in press. doi:10.1038\/mp.2010.33.","DOI":"10.1038\/mp.2010.33"},{"key":"10.1016\/j.jhep.2010.11.006_b1195","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.npp.1301142","article-title":"Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis","volume":"32","author":"Vestri","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jhep.2010.11.006_b1200","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.phrs.2007.05.007","article-title":"Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells","volume":"56","author":"Yang","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jhep.2010.11.006_b1205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-008-1370-x","article-title":"Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver","volume":"203","author":"Ferno","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jhep.2010.11.006_b1210","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1055\/s-2003-43045","article-title":"Risperidone-associated steatohepatitis and excessive weight-gain","volume":"36","author":"Holtmann","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jhep.2010.11.006_b1215","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00004583-199705000-00022","article-title":"Case study: risperidone-induced hepatotoxicity in pediatric patients","volume":"36","author":"Kumra","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jhep.2010.11.006_b1220","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ijo.2009.291","article-title":"Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole","volume":"34","author":"Shertzer","year":"2010","journal-title":"Int J Obes"},{"key":"10.1016\/j.jhep.2010.11.006_b1225","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00210-010-0499-4","article-title":"Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes","volume":"381","author":"Lauressergues","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b1230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11010-006-9160-4","article-title":"SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects?","volume":"289","author":"Raeder","year":"2006","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jhep.2010.11.006_b1235","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eplepsyres.2008.03.017","article-title":"Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children","volume":"80","author":"Rauchenzauner","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jhep.2010.11.006_b1240","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1528-1167.2009.02206.x","article-title":"The metabolic syndrome in overweight epileptic patients treated with valproic acid","volume":"51","author":"Verrotti","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jhep.2010.11.006_b1245","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1210\/en.2004-0877","article-title":"Valproic acid inhibits leptin secretion and reduces leptin messenger ribonucleic acid levels in adipocytes","volume":"145","author":"Lagace","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2010.11.006_b1250","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000197868","article-title":"Valproate-induced insulin resistance and obesity in children","volume":"71","author":"Verrotti","year":"2009","journal-title":"Horm Res"},{"key":"10.1016\/j.jhep.2010.11.006_b1255","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.20074","article-title":"Valproate therapy and nonalcoholic fatty liver disease","volume":"55","author":"Luef","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jhep.2010.11.006_b1260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eplepsyres.2009.04.004","article-title":"Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment","volume":"86","author":"Luef","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jhep.2010.11.006_b1265","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00428-005-0042-z","article-title":"Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid","volume":"447","author":"Sato","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jhep.2010.11.006_b1270","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00431-009-0927-y","article-title":"Nonalcoholic fatty liver disease during valproate therapy","volume":"168","author":"Verrotti","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jhep.2010.11.006_b1275","doi-asserted-by":"crossref","first-page":"G364","DOI":"10.1152\/ajpgi.00456.2009","article-title":"Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice","volume":"298","author":"Shen","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2010.11.006_b1280","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1530-0277.2002.tb02621.x","article-title":"Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion","volume":"26","author":"Cahill","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2010.11.006_b1285","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/hep.22292","article-title":"Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease","volume":"47","author":"Dunn","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/jpet.109.155168","article-title":"Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob\/ob mice","volume":"331","author":"Fromenty","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1295","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7326\/0003-4819-140-6-200403160-00011","article-title":"Effect of alcohol consumption on diabetes mellitus: a systematic review","volume":"140","author":"Howard","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2010.11.006_b1300","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.1840020622","article-title":"Valproate-induced hepatic steatogenesis in rats","volume":"2","author":"Lewis","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1305","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJM196311072691903","article-title":"Fatal liver disease after intravenous administration of tetracycline in high dosage","volume":"269","author":"Schultz","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.11.006_b1310","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.28.9.961","article-title":"Effect of valproic acid on hepatic function","volume":"28","author":"Willmore","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.jhep.2010.11.006_b1315","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1139\/y87-062","article-title":"Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues","volume":"65","author":"Brien","year":"1987","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b1320","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00003495-198836020-00001","article-title":"Recent advances in understanding the pharmacology of amiodarone","volume":"36","author":"Nattel","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.jhep.2010.11.006_b1325","first-page":"161","article-title":"Fatal amiodarone hepatoxicity","volume":"83","author":"Gilinsky","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.11.006_b1330","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1086\/324353","article-title":"Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study","volume":"33","author":"Boubaker","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2010.11.006_b1335","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1086\/649922","article-title":"Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus co-infection","volume":"50","author":"Kovari","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2010.11.006_b1340","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/gut.25.10.1057","article-title":"Impaired oxidation of debrisoquine in patients with perhexiline liver injury","volume":"25","author":"Morgan","year":"1984","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2010.11.006_b1345","first-page":"485","article-title":"CYP17 polymorphism as a risk factor of tamoxifen-induced hepatic steatosis in breast cancer patients","volume":"13","author":"Ohnishi","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jhep.2010.11.006_b1350","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0009-9236(03)00014-6","article-title":"A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus","volume":"73","author":"Watanabe","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1355","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.22370","article-title":"Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury","volume":"48","author":"Lucena","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1360","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.tpj.6500210","article-title":"Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomes","volume":"3","author":"Ho","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jhep.2010.11.006_b1365","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/01480540903207076","article-title":"Drugs interfering with mitochondrial disorders","volume":"33","author":"Finsterer","year":"2010","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.jhep.2010.11.006_b1370","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0887-8994(96)00318-9","article-title":"Medium-chain acyl-CoA dehydrogenase deficiency and fatal valproate toxicity","volume":"16","author":"Njolstad","year":"1997","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jhep.2010.11.006_b1375","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1034\/j.1600-0676.2000.020004346.x","article-title":"Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure","volume":"20","author":"Kr\u00e4henb\u00fchl","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2010.11.006_b1380","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/adc.2007.122911","article-title":"Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase \u03b3 (POLG1)","volume":"93","author":"McFarland","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jhep.2010.11.006_b1385","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/hep.23891","article-title":"Polymerase \u03b3 gene POLG determines the risk of sodium valproate-induced liver toxicity","volume":"52","author":"Stewart","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1390","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1128\/AAC.01659-08","article-title":"R964C mutation of DNA polymerase \u03b3 imparts increased stavudine toxicity by decreasing nucleoside analog discrimination and impairing polymerase activity","volume":"53","author":"Bailey","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2010.11.006_b1395","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/513872","article-title":"Novel mutation of human DNA polymerase gamma associated with mitochondrial toxicity induced by anti-HIV treatment","volume":"195","author":"Yamanaka","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2010.11.006_b1400","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.drudis.2008.08.002","article-title":"The heterozygous Sod2+\/\u2212 mouse: modeling the mitochondrial role in drug toxicity","volume":"13","author":"Boelsterli","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jhep.2010.11.006_b1405","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1053\/gast.2001.24051","article-title":"Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease","volume":"120","author":"Degoul","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b1410","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2007.02.009","article-title":"Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury","volume":"47","author":"Huang","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b1415","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00008571-200303000-00004","article-title":"The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria","volume":"13","author":"Sutton","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jhep.2010.11.006_b1420","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.schres.2007.10.003","article-title":"Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels","volume":"98","author":"de Leon","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jhep.2010.11.006_b1425","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/oby.2005.161","article-title":"Weight change in monozygotic twins treated with valproate","volume":"13","author":"Klein","year":"2005","journal-title":"Obes Res"},{"key":"10.1016\/j.jhep.2010.11.006_b1430","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01213011-200504000-00002","article-title":"Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis","volume":"15","author":"Templeman","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jhep.2010.11.006_b1435","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.3748\/wjg.14.5322","article-title":"Halothane hepatitis in Iran: a review of 59 cases","volume":"14","author":"Eghtesadi-Araghi","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.11.006_b1440","first-page":"99","article-title":"Halothane-related hepatitis. A clinical study of twenty-six cases","volume":"44","author":"Moult","year":"1975","journal-title":"Q J Med"},{"key":"10.1016\/j.jhep.2010.11.006_b1445","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bmj.1.6019.1171","article-title":"Unexplained hepatitis following halothane","volume":"1","author":"Walton","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.jhep.2010.11.006_b1450","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.22536","article-title":"Hepatitis C is a predictor of acute liver injury among hospitalisations for acetaminophen overdose in the United States: a nationwide analysis","volume":"48","author":"Nguyen","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1455","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/bja\/aep322","article-title":"Therapeutic dose of acetaminophen may induce fulminant hepatitis in the presence of risk factors: a report of two cases","volume":"103","author":"Forget","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jhep.2010.11.006_b1460","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1872-034X.2007.00072.x","article-title":"A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease","volume":"37","author":"Tarantino","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2010.11.006_b1465","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/gast.2002.33650","article-title":"Diabetes increases the risk of acute hepatic failure","volume":"122","author":"El-Serag","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b1470","first-page":"1727","article-title":"Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis","volume":"31","author":"Kent","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jhep.2010.11.006_b1475","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1440-1746.2001.02644.x","article-title":"Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury","volume":"16","author":"Langman","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b1480","first-page":"419","article-title":"Amiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failure","volume":"18","author":"Mattar","year":"2009","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.jhep.2010.11.006_b1485","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.hepres.2005.12.001","article-title":"Development of nonalcoholic steatohepatitis model through combination of high-fat diet and tetracycline with morbid obesity in mice","volume":"34","author":"Ito","year":"2006","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2010.11.006_b1490","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1124\/dmd.106.010645","article-title":"Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4\u03b1 expression","volume":"34","author":"Sugatani","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2010.11.006_b1495","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.legalmed.2007.12.006","article-title":"Gene expression on liver toxicity induced by administration of haloperidol in rats with severe fatty liver","volume":"10","author":"Hanagama","year":"2008","journal-title":"Leg Med"},{"key":"10.1016\/j.jhep.2010.11.006_b1500","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1053\/j.gastro.2003.09.019","article-title":"Binge ethanol exposure increases liver injury in obese rats","volume":"125","author":"Carmiel-Haggai","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b1505","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jhep.2004.11.040","article-title":"Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients","volume":"42","author":"Malaguarnera","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b1510","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/hep.20838","article-title":"A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease","volume":"42","author":"Younossi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1515","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1124\/dmd.31.12.1499","article-title":"Acetaminophen-induced hepatotoxicity","volume":"31","author":"James","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2010.11.006_b1520","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1096\/fasebj.6.2.1537462","article-title":"Oxidative and reductive metabolism by cytochrome P450 2E1","volume":"6","author":"Koop","year":"1992","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2010.11.006_b1525","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1074\/jbc.271.20.12063","article-title":"Role of CYP2E1 in the hepatotoxicity of acetaminophen","volume":"271","author":"Lee","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.11.006_b1530","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0022-3565(24)36603-0","article-title":"Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro","volume":"281","author":"Spracklin","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1535","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2003.50095","article-title":"Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis","volume":"37","author":"Chalasani","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1540","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/jhep.2003.50342","article-title":"CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease","volume":"38","author":"Emery","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1545","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/CS20030285","article-title":"Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients","volume":"106","author":"Videla","year":"2004","journal-title":"Clin Sci"},{"key":"10.1016\/j.jhep.2010.11.006_b1550","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.510270121","article-title":"Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis","volume":"27","author":"Weltman","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1555","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00000542-198208000-00005","article-title":"Halothane biotransformation in obese and nonobese patients","volume":"57","author":"Bentley","year":"1982","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jhep.2010.11.006_b1560","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/clpt.1982.111","article-title":"Obesity, sex, and acetaminophen disposition","volume":"31","author":"Abernethy","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1565","first-page":"873","article-title":"Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen","volume":"101","author":"Abernethy","year":"1983","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jhep.2010.11.006_b1570","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/j.1552-4604.1981.tb01768.x","article-title":"The effect of obesity on acetaminophen pharmacokinetics in man","volume":"21","author":"Lee","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jhep.2010.11.006_b1575","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-5347(25)00230-7","article-title":"Obesity as a risk factor in drug-induced organ injury: increased liver and kidney damage by acetaminophen in the obese overfed rat","volume":"241","author":"Corcoran","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1580","doi-asserted-by":"crossref","first-page":"G329","DOI":"10.1152\/ajpgi.00361.2009","article-title":"Diabetic KK-Ay mice are highly susceptible to oxidative hepatocellular damage induced by acetaminophen","volume":"299","author":"Kon","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2010.11.006_b1585","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0022-3565(25)11045-8","article-title":"Phenobarbital induction and acetaminophen hepatotoxicity: resistance in the obese Zucker rodent","volume":"243","author":"Blouin","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1590","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10739680500383423","article-title":"Dietary steatotic liver attenuates acetaminophen hepatotoxicity in mice","volume":"13","author":"Ito","year":"2006","journal-title":"Microcirculation"},{"key":"10.1016\/j.jhep.2010.11.006_b1595","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/bbrc.1999.0202","article-title":"Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob\/ob mice, and fa\/fa Zucker rats","volume":"255","author":"Enriquez","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2010.11.006_b1600","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/bbrc.2000.2125","article-title":"Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob\/ob mice","volume":"268","author":"Leclercq","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2010.11.006_b1605","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1016\/j.febslet.2005.11.029","article-title":"Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes","volume":"579","author":"Robin","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhep.2010.11.006_b1610","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1440-1746.1990.tb01626.x","article-title":"Effect of genetic obesity and experimental diabetes on hepatic microsomal mixed function oxidase activities","volume":"5","author":"Zaluzny","year":"1990","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b1615","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/520092","article-title":"Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients","volume":"196","author":"Labarga","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2010.11.006_b1620","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00126334-200108150-00002","article-title":"Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy","volume":"27","author":"Nunez","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jhep.2010.11.006_b1625","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2036.2008.03745.x","article-title":"Longitudinal effects of hepatitis C virus treatment on hepatic mitochondrial dysfunction assessed by C-methionine breath test","volume":"28","author":"Banasch","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1630","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/hep.21751","article-title":"Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction","volume":"46","author":"Diamond","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1635","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.alcohol.2004.07.004","article-title":"Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins","volume":"34","author":"You","year":"2004","journal-title":"Alcohol"},{"key":"10.1016\/j.jhep.2010.11.006_b1640","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2036.2009.03995.x","article-title":"Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV\u2013HCV co-infected patients","volume":"30","author":"Halfon","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1645","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2006.02.035","article-title":"Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis","volume":"130","author":"Mirandola","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b1650","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.20300","article-title":"Acetaminophen misconceptions","volume":"40","author":"Rumack","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1655","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0889-857X(05)70365-3","article-title":"Methotrexate hepatotoxicity","volume":"23","author":"West","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jhep.2010.11.006_b1660","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/03602530500205200","article-title":"The molecular toxicology of acetaminophen","volume":"37","author":"David-Josephy","year":"2005","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jhep.2010.11.006_b1665","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mrfmmm.2004.04.021","article-title":"Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1","volume":"569","author":"Gonzalez","year":"2005","journal-title":"Mutat Res"},{"key":"10.1016\/j.jhep.2010.11.006_b1670","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2710.2000.00301.x","article-title":"Update: the clinical importance of acetaminophen hepatotoxicity in non-alcoholic and alcoholic subjects","volume":"25","author":"Tanaka","year":"2000","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1675","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.tiv.2007.01.011","article-title":"Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays","volume":"21","author":"Nadanaciva","year":"2007","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.jhep.2010.11.006_b1680","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1586\/14737159.7.2.161","article-title":"Strategies to reduce late-stage drug attrition due to mitochondrial toxicity","volume":"7","author":"Dykens","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jhep.2010.11.006_b1685","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-8278(97)82328-8","article-title":"Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation","volume":"26","author":"Fromenty","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.11.006_b1690","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11154-009-9119-3","article-title":"Role of biological rhythms in gastrointestinal health and disease","volume":"10","author":"Hoogerwerf","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jhep.2010.11.006_b1695","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1053\/gast.2000.9305","article-title":"Biological clocks and the digestive system","volume":"119","author":"Scheving","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.11.006_b1700","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2353\/ajpath.2009.080430","article-title":"The protective role of Per2 against carbon tetrachloride-induced hepatotoxicity","volume":"174","author":"Chen","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2010.11.006_b1705","doi-asserted-by":"crossref","unstructured":"Kakan X, Chen P, Zhang J. Clock gene mPer2 functions in diurnal variation of acetaminophen induced hepatotoxicity in mice. Exp Toxicol Pathol, in press. doi:10.1016\/j.etp.2010.04.011.","DOI":"10.1016\/j.etp.2010.04.011"},{"key":"10.1016\/j.jhep.2010.11.006_b1710","doi-asserted-by":"crossref","first-page":"e1000181","DOI":"10.1371\/journal.pbio.1000181","volume":"7","author":"Le Martelot","year":"2009","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jhep.2010.11.006_b1715","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1096\/fj.09-142000","article-title":"Central nervous system melanocortin-3 receptors are required for synchronizing metabolism during entrainment to restricted feeding during the light cycle","volume":"24","author":"Sutton","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2010.11.006_b1720","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1124\/jpet.108.140186","article-title":"Circadian variations in rat liver gene expression: relationships to drug actions","volume":"326","author":"Almon","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.11.006_b1725","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3109\/07420520903209942","article-title":"Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib","volume":"26","author":"Iurisci","year":"2009","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.jhep.2010.11.006_b1730","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2010.11.006_b1735","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/hep.22332","article-title":"What is idiosyncratic hepatotoxicity? What is it not?","volume":"47","author":"Senior","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.11.006_b1740","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.drudis.2007.02.018","article-title":"Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies","volume":"12","author":"Dixit","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jhep.2010.11.006_b1745","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/tx700186p","article-title":"Idiosyncratic drug reactions: past, present, and future","volume":"21","author":"Uetrecht","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jhep.2010.11.006_b1750","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gut.2008.163675","article-title":"Diagnosis, management and prevention of drug-induced liver injury","volume":"58","author":"Verma","year":"2009","journal-title":"Gut"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810010664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810010664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T20:45:15Z","timestamp":1740689115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827810010664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":350,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0168827810010664"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2010.11.006","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}